Role of Microenvironmental-Derived AXII in Myeloma Bone Disease An Exploratory Model
G
G. David Roodman, MD, PhD
Primary Investigator
Overview
The purpose of this research is to learn if substances that cause bone destruction are increased in multiple myeloma patient's blood or bone marrow.
Description
The purpose of this research is to learn if substances that cause bone destruction are increased in multiple myeloma patient's blood or bone marrow.
Eligibility
You may be eligible for this study if you meet the following criteria:
-
Conditions:
Multiple Myeloma
-
Age: Between 18 Years - 65 Years
-
Gender: All
Inclusion Criteria
Diagnosed with multiple myeloma
Diagnosed with multiple myeloma
Exclusion Criteria
Currently pregnant or breastfeeding
Have a history of bleeding conditions
Participants may be paid for their participation.
Updated on
24 Apr 2024.
Study ID: 1203008199 (IUCRO-0381)